Emmaus Life Sciences, Inc. Receives Notice of Allowance for U.S. Patent for use of L-glutamine in Treatment of Diverticulosis February 01, 2017 Read More
Yutaka Niihara, MD, MPH, CEO of Emmaus Appointed Executive Chairman of Generex Biotechnology CorporationJanuary 25, 2017 Read More
Emmaus Life Sciences, Inc. Receives Japanese Patent for use of L-glutamine in Treatment of DiverticulosisDecember 13, 2016 Read More
Emmaus Life Sciences Receives Notice of FDA PDUFA Date for Investigational L-glutamine Treatment for Sickle Cell DiseaseNovember 30, 2016 Read More
Emmaus’ New Drug Application for Sickle Cell Disease Accepted for Review by FDANovember 08, 2016 Read More
